Merck & Co Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (110)

Latest Posts

About This Stock More About This Stock
Why Are These 6 Dow Stocks Fairly Valued? - Part 4
Video By: Chuck Carnevale
Thursday, October 19, 2017 10:04 AM EDT
I will present a quick overview of six Dow constituents based primarily on price relative to earnings and cash flow.
In this video: AXP, GE, MRK, PFE, TRV, JPM
Watch
Merck Upgraded To Buy From Neutral At Citi
Article By: The Fly
Wednesday, October 18, 2017 6:53 AM EDT
The analyst revised his initial PDx market estimates of $35bn to at least $50bn and increased his 2025 Keytruda forecasts from $9B to$15B.
In this article: MRK Also: LLY, RHHBY
Read
5 Pharma & Biotech Stocks That Could Be Big Winners In Q3 Earnings
Article By: Arpita Dutt
Tuesday, October 10, 2017 4:34 PM EDT
Pharma and biotech stocks started 2017 on a strong note with this part of the market remaining in favor as the year progresses. So far this year, the Nasdaq Biotechnology Index is up 25.6%.
In this article: LLY, MRK, PFE, BIIB, VRTX Also: NVS, GILD
Read
Here's What's Has Happened In The HCV Space Lately
Article By: Zacks Investment Research
Sunday, October 8, 2017 6:08 PM EDT
It is not a surprise that quite a few pharma and biotech companies are working on bringing new, improved, shorter-duration hepatitis C virus (HCV) treatments to the market. The market is thus getting crowded and seeing increased pricing pressure.
In this article: JNJ, GILD, ABBV, MRK Also: BMY
Read
Week In Review: Zai Lab Completes $150 Million US IPO; Investors Push Valuation To $1.4 Billion
Article By: ChinaBio® Today
Saturday, September 23, 2017 5:03 PM EDT
Zai Lab raised $150 million in its US IPO after the company increased the size of the offering to 8 million shares. Demand for the offering was strong, and Zai's stock opened 50% above the IPO price at $27 per share.
In this article: MRK, ZLAB, DMPI
Read

PARTNER HEADLINES

Latest Tweets for $MRK

No tweets yet!

$MRK

OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault 9/6/2017 4:08:15 PM

Thanks for this info, Terry Chrisomalis. Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments